AbbVie Inc.

ABBV · NYSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$5,524,000$12,814,000$9,201,000$9,746,000
Short-Term Investments$31,000$2,000$28,000$84,000
Receivables$10,919,000$11,155,000$11,254,000$9,977,000
Inventory$4,181,000$4,099,000$3,579,000$3,128,000
Other Curr. Assets$4,927,000$4,932,000$4,401,000$0
Total Curr. Assets$25,582,000$33,002,000$28,463,000$27,928,000
Property Plant & Equip (Net)$5,134,000$4,989,000$4,935,000$5,110,000
Goodwill$34,956,000$32,293,000$32,156,000$32,379,000
Intangibles$60,068,000$55,610,000$67,439,000$75,951,000
Long-Term Investments$279,000$304,000$241,000$277,000
Tax Assets$0$0$0$0
Other NC Assets$9,142,000$8,513,000$5,571,000$4,884,000
Total NC Assets$109,579,000$101,709,000$110,342,000$118,601,000
Other Assets$0$0$0$0
Total Assets$135,161,000$134,711,000$138,805,000$146,529,000
Liabilities
Payables$2,945,000$3,688,000$2,934,000$2,882,000
Short-Term Debt$6,804,000$7,191,000$4,302,000$12,673,000
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$27,014,000$25,160,000$20,931,000$17,854,000
Total Curr. Liab.$38,749,000$37,841,000$29,538,000$35,194,000
LT Debt$60,340,000$52,167,000$59,118,000$64,164,000
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$7,628,000$8,633,000$8,692,000$8,979,000
Other NC Liab.$24,383,000$24,911,000$23,399,000$22,018,000
Total NC Liab.$93,048,000$86,473,000$91,980,000$95,899,000
Other Liabilities$0$0$0$0
Cap. Leases$915,000$762,000$771,000$738,000
Total Liabilities$131,797,000$124,314,000$121,518,000$131,093,000
Equity
Pref Stock$0$0$0$0
Common Stock$18,000$18,000$18,000$18,000
Retained Earnings-$7,900,000-$1,000,000$4,784,000$3,127,000
AOCI-$1,925,000-$2,305,000-$2,199,000-$2,899,000
Other Equity$0$0$0$0
Total Equity$3,325,000$10,360,000$17,254,000$15,408,000
Supplemental Information
Minority Interest$39,000$37,000$33,000$28,000
Total Liab. & Tot. Equity$135,161,000$134,711,000$138,805,000$146,529,000
Net Debt$61,620,000$46,544,000$54,219,000$67,091,000